DocGo (DCGO) Expected to Announce Earnings on Thursday

DocGo (NASDAQ:DCGO) will likely be releasing its Q2 2025 earnings data after the market closes on Thursday, August 7th. Analysts expect DocGo to post earnings of ($0.06) per share and revenue of $77.58 million for the quarter. DocGo has set its FY 2025 guidance at EPS.

DocGo (NASDAQ:DCGO) last released its earnings results on Thursday, May 8th. The company reported ($0.09) EPS for the quarter, missing the consensus estimate of ($0.01) by ($0.08). DocGo had a positive return on equity of 2.52% and a negative net margin of 0.12%. The business had revenue of $96.03 million for the quarter, compared to analyst estimates of $104.25 million. On average, analysts expect DocGo to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

DocGo Price Performance

NASDAQ DCGO opened at $1.42 on Thursday. The business has a 50 day simple moving average of $1.50 and a 200 day simple moving average of $2.65. The stock has a market capitalization of $144.81 million, a P/E ratio of -71.00 and a beta of 0.97. DocGo has a one year low of $1.23 and a one year high of $5.68.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the stock. AQR Capital Management LLC lifted its holdings in shares of DocGo by 219.1% in the first quarter. AQR Capital Management LLC now owns 476,645 shares of the company’s stock valued at $1,258,000 after purchasing an additional 327,269 shares in the last quarter. Acadian Asset Management LLC bought a new position in shares of DocGo in the first quarter valued at approximately $338,000. Jane Street Group LLC lifted its holdings in shares of DocGo by 18.8% in the first quarter. Jane Street Group LLC now owns 85,442 shares of the company’s stock valued at $226,000 after purchasing an additional 13,505 shares in the last quarter. Finally, Strs Ohio bought a new position in shares of DocGo in the first quarter valued at approximately $76,000. Institutional investors own 56.44% of the company’s stock.

Wall Street Analysts Forecast Growth

DCGO has been the topic of several recent research reports. Canaccord Genuity Group reiterated a “hold” rating and issued a $1.45 price target (down previously from $5.00) on shares of DocGo in a report on Monday, May 12th. BTIG Research lowered DocGo from a “buy” rating to a “neutral” rating in a report on Friday, May 9th. Finally, Needham & Company LLC cut their price target on DocGo from $4.00 to $3.00 and set a “buy” rating on the stock in a report on Friday, May 9th. Three research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $3.56.

About DocGo

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.